论文部分内容阅读
目的观察匹多莫德分散片辅助治疗儿童反复呼吸道感染临床疗效。方法选取2012年7月—2013年6月就诊的50例反复呼吸道感染患者作为研究对象,随机分为治疗组与对照组各25例。治疗组在常规治疗的基础上予匹多莫德分散片口服0.4 g/次,2次/d,2周后改为0.4 g/次,1次/d。对照组在常规治疗基础上予玉屏风散口服,5 g/次,3次/d。两组疗程均为60 d。计数资料比较采用χ2检验,P<0.05为差异有统计学意义。结果治疗组总有效率为92.0%,对照组为68.0%,比较差异有统计学意义(P<0.05)。两组各种疾病疗效比较差异有统计学意义(P<0.05)。结论匹多莫德分散片辅助治疗反复呼吸道感染,效果满意,无明显不良反应,值得广泛应用。
Objective To observe the clinical efficacy of Pidotimod dispersible tablets in the treatment of recurrent respiratory tract infections in children. Methods Fifty patients with recurrent respiratory tract infection from July 2012 to June 2013 were randomly divided into treatment group (n = 25) and control group (n = 25). On the basis of routine treatment, the treatment group was given podolamod dispersible tablets orally 0.4g / time, 2 times / d, 2 weeks later changed to 0.4g / times, 1 / d. The control group on the basis of conventional treatment to Yupingfeng San oral, 5 g / time, 3 times / d. The two courses of treatment were 60 d. Counting data using χ2 test, P <0.05 for the difference was statistically significant. Results The total effective rate was 92.0% in the treatment group and 68.0% in the control group, the difference was statistically significant (P <0.05). The difference between the two groups of various diseases was statistically significant (P <0.05). Conclusion Pidotimod dispersible tablets adjuvant treatment of recurrent respiratory tract infection, with satisfactory results, no obvious adverse reactions, should be widely used.